Cargando…

Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways

BACKGROUND: To investigate the role and regulatory mechanisms of fargesin, one of the main components of Magnolia fargesii, in macrophage reprogramming and crosstalk across cartilage and synovium during osteoarthritis (OA) development. METHODS: Ten-week-old male C57BL/6 mice were randomized and assi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jiansen, Zhang, Hongbo, Pan, Jianying, Hu, Zhiqiang, Liu, Liangliang, Liu, Yanli, Yu, Xiao, Bai, Xiaochun, Cai, Daozhang, Zhang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120707/
https://www.ncbi.nlm.nih.gov/pubmed/33990219
http://dx.doi.org/10.1186/s13075-021-02512-z
_version_ 1783692151765336064
author Lu, Jiansen
Zhang, Hongbo
Pan, Jianying
Hu, Zhiqiang
Liu, Liangliang
Liu, Yanli
Yu, Xiao
Bai, Xiaochun
Cai, Daozhang
Zhang, Haiyan
author_facet Lu, Jiansen
Zhang, Hongbo
Pan, Jianying
Hu, Zhiqiang
Liu, Liangliang
Liu, Yanli
Yu, Xiao
Bai, Xiaochun
Cai, Daozhang
Zhang, Haiyan
author_sort Lu, Jiansen
collection PubMed
description BACKGROUND: To investigate the role and regulatory mechanisms of fargesin, one of the main components of Magnolia fargesii, in macrophage reprogramming and crosstalk across cartilage and synovium during osteoarthritis (OA) development. METHODS: Ten-week-old male C57BL/6 mice were randomized and assigned to vehicle, collagenase-induced OA (CIOA), or CIOA with intra-articular fargesin treatment groups. Articular cartilage degeneration was evaluated using the Osteoarthritis Research Society International (OARSI) score. Immunostaining and western blot analyses were conducted to detect relative protein. Raw264.7 cells were treated with LPS or IL-4 to investigate the role of polarized macrophages. ADTC5 cells were treated with IL-1β and conditioned medium was collected to investigate the crosstalk between chondrocytes and macrophages. RESULTS: Fargesin attenuated articular cartilage degeneration and synovitis, resulting in substantially lower Osteoarthritis Research Society International (OARSI) and synovitis scores. In particular, significantly increased M2 polarization and decreased M1 polarization in synovial macrophages were found in fargesin-treated CIOA mice compared to controls. This was accompanied by downregulation of IL-6 and IL-1β and upregulation of IL-10 in serum. Conditioned medium (CM) from M1 macrophages treated with fargesin reduced the expression of matrix metalloproteinase-13, RUNX2, and type X collagen and increased Col2a1 and SOX9 in OA chondrocytes, but fargesin alone did not affect chondrocyte catabolic processes. Moreover, fargesin exerted protective effects by suppressing p38/ERK MAPK and p65/NF-κB signaling. CONCLUSIONS: This study showed that fargesin switched the polarized phenotypes of macrophages from M1 to M2 subtypes and prevented cartilage degeneration partially by downregulating p38/ERK MAPK and p65/NF-κB signaling. Targeting macrophage reprogramming or blocking the crosstalk between macrophages and chondrocytes in early OA may be an effective preventive strategy.
format Online
Article
Text
id pubmed-8120707
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81207072021-05-17 Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways Lu, Jiansen Zhang, Hongbo Pan, Jianying Hu, Zhiqiang Liu, Liangliang Liu, Yanli Yu, Xiao Bai, Xiaochun Cai, Daozhang Zhang, Haiyan Arthritis Res Ther Research Article BACKGROUND: To investigate the role and regulatory mechanisms of fargesin, one of the main components of Magnolia fargesii, in macrophage reprogramming and crosstalk across cartilage and synovium during osteoarthritis (OA) development. METHODS: Ten-week-old male C57BL/6 mice were randomized and assigned to vehicle, collagenase-induced OA (CIOA), or CIOA with intra-articular fargesin treatment groups. Articular cartilage degeneration was evaluated using the Osteoarthritis Research Society International (OARSI) score. Immunostaining and western blot analyses were conducted to detect relative protein. Raw264.7 cells were treated with LPS or IL-4 to investigate the role of polarized macrophages. ADTC5 cells were treated with IL-1β and conditioned medium was collected to investigate the crosstalk between chondrocytes and macrophages. RESULTS: Fargesin attenuated articular cartilage degeneration and synovitis, resulting in substantially lower Osteoarthritis Research Society International (OARSI) and synovitis scores. In particular, significantly increased M2 polarization and decreased M1 polarization in synovial macrophages were found in fargesin-treated CIOA mice compared to controls. This was accompanied by downregulation of IL-6 and IL-1β and upregulation of IL-10 in serum. Conditioned medium (CM) from M1 macrophages treated with fargesin reduced the expression of matrix metalloproteinase-13, RUNX2, and type X collagen and increased Col2a1 and SOX9 in OA chondrocytes, but fargesin alone did not affect chondrocyte catabolic processes. Moreover, fargesin exerted protective effects by suppressing p38/ERK MAPK and p65/NF-κB signaling. CONCLUSIONS: This study showed that fargesin switched the polarized phenotypes of macrophages from M1 to M2 subtypes and prevented cartilage degeneration partially by downregulating p38/ERK MAPK and p65/NF-κB signaling. Targeting macrophage reprogramming or blocking the crosstalk between macrophages and chondrocytes in early OA may be an effective preventive strategy. BioMed Central 2021-05-14 2021 /pmc/articles/PMC8120707/ /pubmed/33990219 http://dx.doi.org/10.1186/s13075-021-02512-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lu, Jiansen
Zhang, Hongbo
Pan, Jianying
Hu, Zhiqiang
Liu, Liangliang
Liu, Yanli
Yu, Xiao
Bai, Xiaochun
Cai, Daozhang
Zhang, Haiyan
Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
title Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
title_full Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
title_fullStr Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
title_full_unstemmed Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
title_short Fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating MAPK and NF-κB pathways
title_sort fargesin ameliorates osteoarthritis via macrophage reprogramming by downregulating mapk and nf-κb pathways
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120707/
https://www.ncbi.nlm.nih.gov/pubmed/33990219
http://dx.doi.org/10.1186/s13075-021-02512-z
work_keys_str_mv AT lujiansen fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT zhanghongbo fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT panjianying fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT huzhiqiang fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT liuliangliang fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT liuyanli fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT yuxiao fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT baixiaochun fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT caidaozhang fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways
AT zhanghaiyan fargesinamelioratesosteoarthritisviamacrophagereprogrammingbydownregulatingmapkandnfkbpathways